Migrén: vizsgálatok itt: Japán
7 trials · From ClinicalTrials.gov, checked 2026. november 12.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleRandomized Study in Children and Adolescents With Migraine: Acute Treatment
- Where
- Abeno-ku Osaka-shi, Higashinada-ku Kobe-shi, Hiroshima, Kagoshima, Kasuga-shi, Kiryu-shi, Mito, Naniwa-ku, Nishinomiya-shi, Shibuya-ku, Shinjuku-ku, Taihaku-ku Sendai-shi
- Életkor
- 6 év to 17 év
- People
- 2100 worldwide
- Run by
- Pfizer
See details and how to joinNCT04649242 · EU 2024-512743-23-00 - 3. fázisTaking peopleEfficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
- Where
- Abeno-ku Osaka-shi, Chuo-ku Saitama-shi, Higashinada-ku Kobe-shi, Kagoshima, Kasuga-shi, Kiryu-shi, Kochi, Mito, Naniwa-ku, Nishinomiya-shi, Shibuya-ku, Shinjuku-ku, Taihaku-ku Sendai-shi
- Életkor
- 6 év to 17 év
- People
- 640 worldwide
- Run by
- Pfizer
See details and how to joinNCT05156398 · EU 2024-512382-13-00 - 3. fázisTaking peopleA Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
- Where
- Kagoshima, Kai, Kobe, Kochi, Osaka, Shibuya-ku, Shinjuku-ku, Tendo-shi
- Életkor
- 12 év to 17 év
- People
- 420 worldwide
- Run by
- AbbVie
See details and how to joinNCT06810505 · EU 2024-513836-28-00 - 3. fázisTaking peopleA Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine
- Where
- Kobe, Kochi, Kyoto, Nishinomiya, Osaka, Sendai, Shinjuku-ku
- Életkor
- 6 év to 17 év
- People
- 450 worldwide
- Run by
- AbbVie
See details and how to joinNCT05711394 · EU 2022-501100-94-00 - 3. fázisTaking peopleA Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine
- Where
- Kagoshima, Kai, Kobe, Kyoto-shi Shimogyo-ku, Sendai, Shibuya-ku
- Életkor
- 18 év to 45 év
- People
- 723 worldwide
- Run by
- Pfizer
See details and how to joinNCT06641466 · EU 2024-517121-10-00 - No phaseTaking peopleSpecified Drug Use Survey on AJOVY Subcutaneous Injection for Long-term Use
- Where
- Osaka
- Életkor
- 18 év and over
- People
- 1000
- Run by
- Otsuka Pharmaceutical Co., Ltd.
See details and how to joinNCT05342493 - 3. fázisCsak meghívásosLong-term Extension Study to Assess Adverse Events of Oral Atogepant Tablets in Pediatric Participants (6 to 17 Years of Age) With Migraine
- Where
- Kobe, Kochi, Kyoto, Nishinomiya-shi, Osaka, Sendai, Shinjuku-ku
- Életkor
- 6 év to 17 év
- People
- 650 worldwide
- Run by
- AbbVie
See details and how to joinNCT05707949 · EU 2022-501099-24-00